Concomitant Coronary(수반되는 관상동맥)란 무엇입니까?
Concomitant Coronary 수반되는 관상동맥 - Purpose Patients with cirrhosis and concomitant coronary/valvular heart disease present a clinical dilemma. [1] In patients with PAD who have clinical evidence of concomitant coronary or cerebrovascular disease, aspirin or clopidogrel would be first-line treatment. [2]목 적 간경변과 동반된 관상동맥/판막 심장 질환이 있는 환자는 임상적 딜레마를 나타냅니다. [1] 관상동맥질환이나 뇌혈관질환을 동반한 임상적 증거가 있는 말초동맥질환 환자의 경우 아스피린이나 클로피도그렐이 1차 치료제가 될 것이다. [2]
artery bypass grafting 동맥 우회 이식
028); and concomitant coronary artery bypass grafting (OR 2. [1] Combined coronary artery bypass grafting (CABG) and carotid endarterectomy (CEA) procedures can be done in individuals who have concomitant coronary and carotid artery disease. [2] BACKGROUND In this study, we investigated the impact of concomitant coronary artery bypass grafting (CABG) on operative and midterm mortality in patients with acute type A aortic dissection (ATAAD) undergoing surgical repair. [3] These patients underwent concomitant coronary artery bypass grafting less frequently with a lower number of distal anastomoses (p Conclusions In patients with ischemic mitral regurgitation, a history of previous multiple percutaneous coronary interventions was associated with increased risk of long-term post-operative mortality, with less improvement in left ventricular ejection fraction. [4] A Bentall operation with concomitant coronary artery bypass grafting was successfully performed with a composite graft. [5] Concomitant coronary artery bypass grafting has been demonstrated to improve long-term survival in those patients undergoing ventricular septal defect repair. [6] Significant predictors determined by univariate analysis were concomitant coronary artery bypass grafting (CABG) (P = 0. [7] To compare the results of biatrial (BA) and left atrial ablation (LAA) performed in patients with long-standing persistent atrial fibrillation (AF) with concomitant coronary artery disease (CAD) with indication for coronary artery bypass grafting (CABG). [8] Four patients underwent concomitant coronary artery bypass grafting. [9] All patients underwent ascending aorta replacement with modified technique; an additional open subvalvular ring was used in 8 patients with aortic insufficiency ≥ 2; cusps repair was performed in 6 patients (5 plicating central stitches/1 shaving); concomitant coronary artery bypass grafting was performed in 10 patients. [10] Background: It is current practice to perform concomitant coronary artery bypass grafting (CABG) in patients with infective endocarditis (IE) who have relevant coronary artery disease (CAD). [11] Concomitant coronary artery bypass grafting was performed in 60 patients (34. [12] Concomitant coronary artery bypass grafting (CABG) was done in 22 patients (63%) but did not influence survival. [13] Concomitant coronary artery bypass grafting (26. [14] Between May 2008 and February 2018, 219 consecutive patients undergoing heart valve replacement surgery with or without concomitant coronary artery bypass grafting (CAGB) were included in the study. [15] In addition, concomitant coronary artery bypass grafting for coronary artery disease was also an independent predictor of cardiovascular mortality (hazard ratio 5. [16] Patients undergoing isolated MVP (n = 133) and concomitant coronary artery bypass grafting or other valvular procedures (N = 170) were included. [17] Urgent mitral valve replacement and concomitant coronary artery bypass grafting were performed. [18] Concomitant coronary artery bypass grafting and other heart valve or other major open-heart procedures were excluded. [19] Although selected patients undergo concomitant coronary artery bypass grafting (CABG) at the time of LVAD implantation, the detailed implication of this combined surgical approach is not yet well studied. [20] Concomitant coronary artery bypass grafting was performed in 475 (34. [21] Patients undergoing concomitant coronary artery bypass grafting had higher odds of CR enrollment (OR, 1. [22] On-pump complete extirpation of the tumour with concomitant coronary artery bypass grafting was performed successfully. [23] Methods All patients with preexisting chronic kidney disease who underwent SAVR for aortic stenosis with or without concomitant coronary artery bypass grafting or TAVR from 5/2008 to 6/2017. [24] Methods: Based on the type of the utilized ECC, we performed a retrospective propensity score-matched comparison among all octogenarians (n = 218) who received a primary AVR with or without concomitant coronary artery bypass grafting in our institution between 2003 and 2010. [25] The age-dependent risk of atrial fibrillation at 12 months was significantly increased in elderly patients undergoing a concomitant coronary artery bypass grafting surgery. [26] Results were adjusted for baseline features (age, sex, comorbidity burden, atrial fibrillation, valvular stenosis, concomitant coronary artery bypass grafting, extension, urgency, year and centre of operation). [27] In the TVrepair group, females were significantly older, had less prior percutaneous/surgical coronary interventions, less extracardiac arteriopathies, a lower prevalence of renal impairment, less endocarditis, a lower prevalence of preoperative critical condition, less recent myocardial infarction, less concomitant coronary artery bypass grafting (CABG) and, in case of concomitant mitral valve surgery, less concomitant mitral valve repair compared to males. [28] Exclusion criteria included functional mitral regurgitation, rheumatic disease, active endocarditis, and concomitant coronary artery bypass grafting or complex aortic surgery. [29] To To the Editor: In a single-center perspective study by Chen [1] et al determining the risk factors and predictors of shortobtain the true inferences ofmultivariable regression analysis term mortality after valve surgery, multivariate logistic regression analysis showed that pre-operative New York Heart Association functional class 4, smoking history, poor ejection fraction, previous cardiac surgery, moderate or severe tricuspid regurgitation, and concomitant coronary artery bypass grafting were potential risk factors for shortterm mortality. [30]028); 및 수반되는 관상동맥 우회술(또는 2. [1] 관상동맥우회술(CABG)과 경동맥내막절제술(CEA)을 병행하는 시술은 관상동맥질환과 경동맥질환이 있는 사람에게 시행할 수 있습니다. [2] nan [3] 이 환자들은 원위부 문합 횟수가 적으면서 동시에 관상동맥 우회술을 덜 자주 시행받았습니다. 좌심실 박출률의 개선이 적습니다. [4] nan [5] nan [6] nan [7] nan [8] 4명의 환자가 관상동맥 우회술을 동시에 받았습니다. [9] nan [10] nan [11] 60명의 환자(34명)에서 관상동맥우회술을 동시에 시행하였다. [12] 22명의 환자(63%)에서 관상동맥우회술(CABG)이 동시에 시행되었지만 생존에 영향을 미치지는 않았습니다. [13] nan [14] 2008년 5월과 2018년 2월 사이에 관상동맥 우회술(CAGB)을 수반하거나 수반하지 않는 심장 판막 교체 수술을 받은 219명의 연속 환자가 연구에 포함되었습니다. [15] nan [16] nan [17] nan [18] nan [19] nan [20] nan [21] 관상동맥 우회술을 병행하는 환자는 CR 등록 확률이 더 높았습니다(OR, 1. [22] nan [23] 방법 2008년 5월부터 2017년 6월까지 관상동맥 우회술 또는 TAVR을 동반하거나 동반하지 않은 대동맥 협착증에 대해 SAVR을 받은 기존의 만성 신장 질환이 있는 모든 환자. [24] nan [25] nan [26] nan [27] nan [28] nan [29] nan [30]
artery bypass graft 동맥 우회 이식
METHODS From the nationwide Danish Register of Surgical Procedures, we identified all patients ≥40 years with isolated bio-SAVR ± concomitant coronary artery bypass graft surgery (CABG) during 2000-2016. [1] BACKGROUND The optimal prosthesis for aortic valve replacement (AVR) with concomitant coronary artery bypass graft (CABG) is controversial. [2] Among COPD patients, IHM was associated with older age, more comorbidities and concomitant coronary artery bypass graft. [3] Higher IHM after SAVR was associated with older age, comorbidities (except diabetes and atrial fibrillation), concomitant coronary artery bypass graft and emergency room admission. [4]행동 양식 덴마크 전국 외과 수술 등록부에서 2000-2016년 동안 단독 bio-SAVR ± 수반되는 관상동맥 우회 이식 수술(CABG)을 받은 40 세 이상의 모든 환자를 확인했습니다. [1] 배경 관상동맥우회술(CABG)을 동반한 대동맥판막 치환술(AVR)을 위한 최적의 인공삽입물은 논란의 여지가 있습니다. [2] COPD 환자 중 IHM은 고령, 더 많은 동반 질환 및 수반되는 관상 동맥 우회 이식과 관련이 있습니다. [3] SAVR 후 더 높은 IHM은 고령, 동반질환(당뇨병 및 심방세동 제외), 수반되는 관상동맥 우회술 및 응급실 입원과 관련이 있었습니다. [4]
chronic obstructive pulmonary 만성 폐쇄성 폐
If this finding can be applied to patients with chronic obstructive pulmonary disease (COPD) and concomitant coronary artery disease (CAD) is unknown. [1] Multivariable analysis identified ten significant predictors for POP in the derivation set, including older age, smoking history, chronic obstructive pulmonary disease, diabetes mellitus, renal insufficiency, poor cardiac function, heart surgery history, longer cardiopulmonary bypass, blood transfusion, and concomitant coronary and/or aortic surgery. [2] The study aims to analyze the effect of the combination of Mexicor and Polyoxidonium on the cardiovascular system in patients with chronic obstructive pulmonary disease (COPD) and concomitant coronary heart disease (CHD). [3] Age, chronic obstructive pulmonary disease, concomitant coronary revascularization, frailty stratified according to the Geriatric Status Scale, urgent procedure and estimated glomerular filtration rate were independent predictors of 30-day mortality. [4]이 발견이 만성 폐쇄성 폐질환(COPD)과 동반되는 관상동맥질환(CAD) 환자에게 적용될 수 있는지 여부는 알려지지 않았다. [1] 다변수 분석은 고령, 흡연 이력, 만성 폐쇄성 폐질환, 당뇨병, 신부전, 심장 기능 저하, 심장 수술 이력, 긴 심폐 바이패스, 수혈 및 수반되는 관상동맥 및 /또는 대동맥 수술. [2] nan [3] nan [4]
coronary artery disease
Conclusions Bilateral renal artery stenosis is significantly associated with increased left ventricular hypertrophy/concentric hypertrophy in patients with suspected concomitant coronary and renal artery disease, while no synergic effect could be found in coronary artery disease. [1] Patients with systemic hypertension, diabetes mellitus type-II, congenital heart defects, coronary artery disease, non-rheumatic valvular degeneration, positive test for hepatitis C, or undergoing concomitant coronary artery bypass graft or a ‘redo’ valve replacement procedure were excluded. [2]결론 양측 신동맥 협착은 관상동맥 및 신동맥 질환이 의심되는 환자에서 좌심실 비대/동심성 비대 증가와 유의하게 관련이 있는 반면, 관상동맥 질환에서는 상승 효과를 발견할 수 없었다. [1] 전신성 고혈압, 제2형 당뇨병, 선천성 심장 결함, 관상동맥 질환, 비류마티스 판막 변성, C형 간염 양성 검사, 관상동맥 우회 이식술 또는 '재실행' 판막 교체 시술을 받은 환자는 제외되었습니다. [2]
artery bypass surgery 동맥 우회 수술
Methods: Retrospective database analysis between 2010 and 2016 revealed 214 patients undergoing transcatheter aortic valve implantation procedures through surgical access (predominantly transapical) and 62 sutureless and rapid-deployment aortic valve procedures including 26 patients in need of concomitant coronary artery bypass surgery. [1] 8 years of follow-up were determined in 673 patients who underwent aortic valve replacement with or without concomitant coronary artery bypass surgery for severe aortic stenosis and/or regurgitation. [2]방법: 2010년과 2016년 사이의 후향적 데이터베이스 분석에 따르면 214명의 환자가 외과적 접근(주로 경추)을 통해 경동맥 대동맥 판막 이식 절차를 받았고 62명의 무봉합 및 급속 전개 대동맥 판막 절차가 있었으며 이 중 26명은 관상동맥 우회 수술이 필요한 환자였습니다. [1] 심각한 대동맥 협착 및/또는 역류로 인해 관상동맥 우회 수술을 동반하거나 동반하지 않고 대동맥판막 치환술을 받은 673명의 환자에서 8년의 추적 관찰이 결정되었습니다. [2]
concomitant mitral valve
Surgery for infective endocarditis consisted of a Bentall procedure in 10 patients, 2 of which received concomitant mitral valve surgery and 2 received concomitant coronary artery bypass graft. [1]감염성 심내막염에 대한 수술은 10명의 환자에서 Bentall 시술로 구성되었으며, 이 중 2명은 승모판 수술을, 2명은 관상동맥 우회 이식을 받았습니다. [1]
mitral valve surgery
The right ventricular dysfunction could be due to the concomitant coronary artery disease or air embolism during the beating mitral valve surgery. [1]우심실 기능 장애는 박동 승모판 수술 중 수반되는 관상 동맥 질환 또는 공기 색전증으로 인한 것일 수 있습니다. [1]
Without Concomitant Coronary 수반되는 관상동맥 없이
To evaluate the paracrine effects of EF and detect the association of tissue Doppler imaging (TDI) parameters, EF thickness by cardiac magnetic resonance tomography (CMR) and biochemical markers of fibrosis and inflammation in patients with nonvalvular AF without concomitant coronary artery disease. [1] 8 years of follow-up were determined in 673 patients who underwent aortic valve replacement with or without concomitant coronary artery bypass surgery for severe aortic stenosis and/or regurgitation. [2] 14%) than without concomitant coronary heart disease - 35. [3] Between May 2008 and February 2018, 219 consecutive patients undergoing heart valve replacement surgery with or without concomitant coronary artery bypass grafting (CAGB) were included in the study. [4] Methods All patients with preexisting chronic kidney disease who underwent SAVR for aortic stenosis with or without concomitant coronary artery bypass grafting or TAVR from 5/2008 to 6/2017. [5] Here we prospectively studied the influence of traditional cardiovascular risk factors on AS development requiring surgery among patients without concomitant coronary artery disease (CAD) and stratified for age. [6] Methods: Based on the type of the utilized ECC, we performed a retrospective propensity score-matched comparison among all octogenarians (n = 218) who received a primary AVR with or without concomitant coronary artery bypass grafting in our institution between 2003 and 2010. [7]EF의 측분비 효과를 평가하고 조직 도플러 영상(TDI) 매개변수, 심장 자기 공명 단층 촬영(CMR)에 의한 EF 두께 및 동반되는 관상 동맥 질환이 없는 판막 AF가 있는 환자에서 섬유증 및 염증의 생화학적 마커의 연관성을 감지하기 위해. [1] 심각한 대동맥 협착 및/또는 역류로 인해 관상동맥 우회 수술을 동반하거나 동반하지 않고 대동맥판막 치환술을 받은 673명의 환자에서 8년의 추적 관찰이 결정되었습니다. [2] nan [3] 2008년 5월과 2018년 2월 사이에 관상동맥 우회술(CAGB)을 수반하거나 수반하지 않는 심장 판막 교체 수술을 받은 219명의 연속 환자가 연구에 포함되었습니다. [4] 방법 2008년 5월부터 2017년 6월까지 관상동맥 우회술 또는 TAVR을 동반하거나 동반하지 않은 대동맥 협착증에 대해 SAVR을 받은 기존의 만성 신장 질환이 있는 모든 환자. [5] nan [6] nan [7]
Undergoing Concomitant Coronary
Patients undergoing concomitant coronary artery bypass grafting had higher odds of CR enrollment (OR, 1. [1] Patients with systemic hypertension, diabetes mellitus type-II, congenital heart defects, coronary artery disease, non-rheumatic valvular degeneration, positive test for hepatitis C, or undergoing concomitant coronary artery bypass graft or a ‘redo’ valve replacement procedure were excluded. [2]관상동맥 우회술을 병행하는 환자는 CR 등록 확률이 더 높았습니다(OR, 1. [1] 전신성 고혈압, 제2형 당뇨병, 선천성 심장 결함, 관상동맥 질환, 비류마티스 판막 변성, C형 간염 양성 검사, 관상동맥 우회 이식술 또는 '재실행' 판막 교체 시술을 받은 환자는 제외되었습니다. [2]
Les Concomitant Coronary
Patients with UAV stenosis require less concomitant coronary or other cardiac procedures when they need surgical intervention, but are about a decade younger at the time of their death. [1] In the TVrepair group, females were significantly older, had less prior percutaneous/surgical coronary interventions, less extracardiac arteriopathies, a lower prevalence of renal impairment, less endocarditis, a lower prevalence of preoperative critical condition, less recent myocardial infarction, less concomitant coronary artery bypass grafting (CABG) and, in case of concomitant mitral valve surgery, less concomitant mitral valve repair compared to males. [2]Underwent Concomitant Coronary 수반되는 관상동맥을 겪었다
These patients underwent concomitant coronary artery bypass grafting less frequently with a lower number of distal anastomoses (p Conclusions In patients with ischemic mitral regurgitation, a history of previous multiple percutaneous coronary interventions was associated with increased risk of long-term post-operative mortality, with less improvement in left ventricular ejection fraction. [1] Four patients underwent concomitant coronary artery bypass grafting. [2]이 환자들은 원위부 문합 횟수가 적으면서 동시에 관상동맥 우회술을 덜 자주 시행받았습니다. 좌심실 박출률의 개선이 적습니다. [1] 4명의 환자가 관상동맥 우회술을 동시에 받았습니다. [2]
concomitant coronary artery 수반되는 관상동맥
028); and concomitant coronary artery bypass grafting (OR 2. [1] If this finding can be applied to patients with chronic obstructive pulmonary disease (COPD) and concomitant coronary artery disease (CAD) is unknown. [2] BACKGROUND In this study, we investigated the impact of concomitant coronary artery bypass grafting (CABG) on operative and midterm mortality in patients with acute type A aortic dissection (ATAAD) undergoing surgical repair. [3] These patients underwent concomitant coronary artery bypass grafting less frequently with a lower number of distal anastomoses (p Conclusions In patients with ischemic mitral regurgitation, a history of previous multiple percutaneous coronary interventions was associated with increased risk of long-term post-operative mortality, with less improvement in left ventricular ejection fraction. [4] METHODS From the nationwide Danish Register of Surgical Procedures, we identified all patients ≥40 years with isolated bio-SAVR ± concomitant coronary artery bypass graft surgery (CABG) during 2000-2016. [5] A Bentall operation with concomitant coronary artery bypass grafting was successfully performed with a composite graft. [6] RESULTS Results: The following article is dedicated to studying on the effectiveness of the proposed method of GP I and II degree of development treatment in patients with a concomitant coronary artery disease (CAD) using of herbal medicines with immunomodulating effect. [7] Patients with PAD and HF had over twice the rate of concomitant coronary artery disease as those without HF. [8] Concomitant coronary artery bypass grafting has been demonstrated to improve long-term survival in those patients undergoing ventricular septal defect repair. [9] Background Concomitant coronary artery disease (CAD) and atrial fibrillation (AF) are common in clinical practice. [10] Management of concomitant coronary artery disease (CAD) in these patients remains controversial with no randomized clinical trials to guide decision making in this cohort. [11] BACKGROUND The optimal prosthesis for aortic valve replacement (AVR) with concomitant coronary artery bypass graft (CABG) is controversial. [12] Significant predictors determined by univariate analysis were concomitant coronary artery bypass grafting (CABG) (P = 0. [13] The patients were categorized, based on concomitant coronary artery stenosis detected by angiography, as CCAE group (n=87, ≥30% luminal stenosis) and ICAE group (n=56, <30% luminal stenosis) and also categorized by the coronary flow as CSFP group (n=51) and normal flow coronary ectasia - NCEA group (n=92). [14] To compare the results of biatrial (BA) and left atrial ablation (LAA) performed in patients with long-standing persistent atrial fibrillation (AF) with concomitant coronary artery disease (CAD) with indication for coronary artery bypass grafting (CABG). [15] Methods: Retrospective database analysis between 2010 and 2016 revealed 214 patients undergoing transcatheter aortic valve implantation procedures through surgical access (predominantly transapical) and 62 sutureless and rapid-deployment aortic valve procedures including 26 patients in need of concomitant coronary artery bypass surgery. [16] To evaluate the paracrine effects of EF and detect the association of tissue Doppler imaging (TDI) parameters, EF thickness by cardiac magnetic resonance tomography (CMR) and biochemical markers of fibrosis and inflammation in patients with nonvalvular AF without concomitant coronary artery disease. [17] These include age, valve morphology and pathophysiology, presence of concomitant coronary artery disease and ascending aortic and root aneurysm. [18] Of note, nearly 30% of AF patients also present with concomitant coronary artery disease requiring percutaneous coronary intervention (PCI) as well as dual antiplatelet therapy (DAPT) to prevent adverse cardiac events. [19] Four patients underwent concomitant coronary artery bypass grafting. [20] All patients underwent ascending aorta replacement with modified technique; an additional open subvalvular ring was used in 8 patients with aortic insufficiency ≥ 2; cusps repair was performed in 6 patients (5 plicating central stitches/1 shaving); concomitant coronary artery bypass grafting was performed in 10 patients. [21] Decision-making regarding therapy choice should be based on individual anatomy (including the number of leaflets, annular size, and peripheral arterial anatomy), comorbidities (including concomitant coronary artery disease and aortopathies), and patient preference guide. [22] In addition, two patients had diabetes and one patient had concomitant coronary artery disease. [23] Concomitant coronary artery bypass (conCABG) was BP 206(21. [24] 8 years of follow-up were determined in 673 patients who underwent aortic valve replacement with or without concomitant coronary artery bypass surgery for severe aortic stenosis and/or regurgitation. [25] The control rate of low-density lipoprotein-C (LDL-C) in patients with concomitant coronary artery disease (CAD), diabetes (DM), and chronic kidney disease (CKD) was 24. [26] The majority of CTO patients had concomitant coronary artery disease in at least one non-CTO vessel (n=37, 54. [27] In this case report, we present an innovative approach for addressing concomitant coronary artery disease and TAA repair using double-arterial cannulation and differential hypothermic circulatory arrest without any postoperative neurological sequelae. [28] Blood pressure control is essential prior to coronary intervention in patients with resistant hypertension and concomitant coronary artery disease to prevent haemorrhagic stroke and other unwanted complications. [29] Aim of this single‐center retrospective study was to assess early outcomes of a totally micro‐invasive strategy (percutaneous coronary intervention—PCI—followed by transapical off‐pump NeoChord mitral repair) in patients with concomitant coronary artery disease (CAD) and degenerative mitral regurgitation (MR). [30] Background: It is current practice to perform concomitant coronary artery bypass grafting (CABG) in patients with infective endocarditis (IE) who have relevant coronary artery disease (CAD). [31] Among COPD patients, IHM was associated with older age, more comorbidities and concomitant coronary artery bypass graft. [32] Concomitant coronary artery bypass grafting was performed in 60 patients (34. [33] Concomitant coronary artery bypass grafting (CABG) was done in 22 patients (63%) but did not influence survival. [34] SAPT has a limited role in the treatment of asymptomatic PAD, particularly in the absence of concomitant coronary artery disease. [35] Concomitant coronary artery bypass grafting (26. [36] Between May 2008 and February 2018, 219 consecutive patients undergoing heart valve replacement surgery with or without concomitant coronary artery bypass grafting (CAGB) were included in the study. [37] Five patients required concomitant coronary artery bypass surgery. [38] The results of the literature review have shown that preference is given to the regional methods of anesthesia as they allow patients to maintain a dietary pattern and insulin regimen, to reduce the risk of intraoperative complications in concomitant coronary artery disease, heart failure, cardiac arrhythmias, hypertension, renal failure, and pulmonary embolism incidence. [39] Concomitant coronary artery involvement suggested a worse outcome. [40] Optimal management of concomitant coronary artery disease and carotid artery stenosis remains unknown. [41] In patients with atrial fibrillation (AF), concomitant coronary artery disease is often present, and vice versa. [42] In addition, concomitant coronary artery bypass grafting for coronary artery disease was also an independent predictor of cardiovascular mortality (hazard ratio 5. [43] Patients undergoing isolated MVP (n = 133) and concomitant coronary artery bypass grafting or other valvular procedures (N = 170) were included. [44] BACKGROUND Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in the need of additional antithrombotic therapy. [45] One in three patients suffering from atrial fibrillation (AF) develops concomitant coronary artery disease. [46] Urgent mitral valve replacement and concomitant coronary artery bypass grafting were performed. [47] Concomitant coronary artery bypass grafting and other heart valve or other major open-heart procedures were excluded. [48] Although selected patients undergo concomitant coronary artery bypass grafting (CABG) at the time of LVAD implantation, the detailed implication of this combined surgical approach is not yet well studied. [49] Background Diabetic cardiomyopathy (DM CMP) is defined as cardiomyocyte damage and ventricular dysfunction directly associated with diabetes independent of concomitant coronary artery disease or hypertension. [50]028); 및 수반되는 관상동맥 우회술(또는 2. [1] 이 발견이 만성 폐쇄성 폐질환(COPD)과 동반되는 관상동맥질환(CAD) 환자에게 적용될 수 있는지 여부는 알려지지 않았다. [2] nan [3] 이 환자들은 원위부 문합 횟수가 적으면서 동시에 관상동맥 우회술을 덜 자주 시행받았습니다. 좌심실 박출률의 개선이 적습니다. [4] 행동 양식 덴마크 전국 외과 수술 등록부에서 2000-2016년 동안 단독 bio-SAVR ± 수반되는 관상동맥 우회 이식 수술(CABG)을 받은 40 세 이상의 모든 환자를 확인했습니다. [5] nan [6] 결과 결과: 다음 기사는 면역 조절 효과가 있는 한약을 사용하여 관상 동맥 질환(CAD)을 동반한 환자에서 제안된 GP I 및 II 발달 정도 치료 방법의 효과에 대한 연구에 전념합니다. [7] PAD와 HF가 있는 환자는 HF가 없는 환자에 비해 관상동맥 질환을 동반한 비율이 2배 이상이었습니다. [8] nan [9] nan [10] 이 환자들에서 수반되는 관상 동맥 질환(CAD)의 관리는 이 코호트에서 의사 결정을 안내하는 무작위 임상 시험이 없기 때문에 논란의 여지가 남아 있습니다. [11] 배경 관상동맥우회술(CABG)을 동반한 대동맥판막 치환술(AVR)을 위한 최적의 인공삽입물은 논란의 여지가 있습니다. [12] nan [13] 환자는 혈관조영술에서 발견된 동반되는 관상동맥 협착을 기준으로 CCAE군(n=87, ≥30% 관강 협착)과 ICAE 군(n=56, <30% 관강 협착)으로 분류하고 관상동맥 혈류에 따라 분류했습니다. CSFP 그룹(n=51) 및 정상 혈류 관상동맥 확장증 - NCEA 그룹(n=92)으로. [14] nan [15] 방법: 2010년과 2016년 사이의 후향적 데이터베이스 분석에 따르면 214명의 환자가 외과적 접근(주로 경추)을 통해 경동맥 대동맥 판막 이식 절차를 받았고 62명의 무봉합 및 급속 전개 대동맥 판막 절차가 있었으며 이 중 26명은 관상동맥 우회 수술이 필요한 환자였습니다. [16] EF의 측분비 효과를 평가하고 조직 도플러 영상(TDI) 매개변수, 심장 자기 공명 단층 촬영(CMR)에 의한 EF 두께 및 동반되는 관상 동맥 질환이 없는 판막 AF가 있는 환자에서 섬유증 및 염증의 생화학적 마커의 연관성을 감지하기 위해. [17] 여기에는 연령, 판막 형태 및 병태생리학, 수반되는 관상 동맥 질환의 존재, 상행 대동맥 및 뿌리 동맥류가 포함됩니다. [18] 참고로 AF 환자의 거의 30%는 심장 부작용을 예방하기 위해 경피적 관상동맥 중재술(PCI)과 이중 항혈소판 요법(DAPT)이 필요한 관상동맥 질환을 동반합니다. [19] 4명의 환자가 관상동맥 우회술을 동시에 받았습니다. [20] nan [21] 치료 선택에 관한 결정은 개인의 해부학적 구조(소엽 수, 고리 모양의 크기, 말초 동맥 해부학 포함), 동반 질환(관상 동맥 질환 및 대동맥 병증을 동반한 질병 포함), 환자 선호도 가이드를 기반으로 해야 합니다. [22] 또한 2명의 환자는 당뇨병이 있었고 1명의 환자는 관상동맥 질환이 있었습니다. [23] 수반되는 관상동맥 우회로(conCABG)는 BP 206(21. [24] 심각한 대동맥 협착 및/또는 역류로 인해 관상동맥 우회 수술을 동반하거나 동반하지 않고 대동맥판막 치환술을 받은 673명의 환자에서 8년의 추적 관찰이 결정되었습니다. [25] 관상 동맥 질환(CAD), 당뇨병(DM), 만성 신장 질환(CKD)을 동반한 환자에서 저밀도 지단백-C(LDL-C)의 통제율은 24명이었습니다. [26] 대부분의 CTO 환자는 하나 이상의 non-CTO 혈관에 관상동맥 질환을 동반했습니다(n=37, 54. [27] nan [28] 출혈성 뇌졸중 및 기타 원치 않는 합병증을 예방하기 위해 저항성 고혈압 및 동반된 관상동맥 질환이 있는 환자에서 관상동맥 중재술 전에 혈압 조절이 필수적입니다. [29] 이 단일 센터 후향적 연구의 목적은 관상동맥 질환(CAD)과 퇴행성 승모판막이 동반된 환자에서 완전 미세 침습적 전략(경피적 관상동맥 중재술(PCI) 후 경추 오프 펌프 NeoChord 승모판 수리)의 초기 결과를 평가하는 것이었습니다. 역류(MR). [30] nan [31] COPD 환자 중 IHM은 고령, 더 많은 동반 질환 및 수반되는 관상 동맥 우회 이식과 관련이 있습니다. [32] 60명의 환자(34명)에서 관상동맥우회술을 동시에 시행하였다. [33] 22명의 환자(63%)에서 관상동맥우회술(CABG)이 동시에 시행되었지만 생존에 영향을 미치지는 않았습니다. [34] SAPT는 특히 동반되는 관상동맥 질환이 없는 경우 무증상 PAD의 치료에 제한된 역할을 합니다. [35] nan [36] 2008년 5월과 2018년 2월 사이에 관상동맥 우회술(CAGB)을 수반하거나 수반하지 않는 심장 판막 교체 수술을 받은 219명의 연속 환자가 연구에 포함되었습니다. [37] nan [38] 문헌 검토 결과에 따르면 환자가식이 패턴과 인슐린 요법을 유지하고 수반되는 관상 동맥 질환, 심부전, 심장 부정맥의 위험을 줄이기 위해 국소 마취 방법이 선호됩니다. 고혈압, 신부전, 폐색전증 발병률. [39] 동반된 관상동맥 침범은 더 나쁜 결과를 시사했습니다. [40] 수반되는 관상동맥 질환 및 경동맥 협착증의 최적 관리는 아직 알려지지 않았습니다. [41] 심방세동(AF) 환자에서 수반되는 관상동맥 질환이 종종 존재하며 그 반대도 마찬가지입니다. [42] nan [43] nan [44] 배경 심방세동이 있는 많은 환자는 급성 관상동맥 증후군을 동반하거나 동반하지 않는 관상동맥 질환을 갖고 있으며 추가적인 항혈전 치료가 필요합니다. [45] nan [46] nan [47] nan [48] nan [49] 배경 당뇨병성 심근병증(DM CMP)은 수반되는 관상 동맥 질환 또는 고혈압과 무관하게 당뇨병과 직접적으로 관련된 심근 세포 손상 및 심실 기능 장애로 정의됩니다. [50]
concomitant coronary revascularization 수반되는 관상동맥 재관류
Patients with TAV more often needed concomitant coronary revascularization (OR, 3. [1] Concomitant coronary revascularization occurred in 70% of matched IMR patients. [2] This is an alternative to the more widely used technique of ascending aorta to bifemoral bypass and concomitant coronary revascularization. [3] However, surgery is spared for cases that require concomitant coronary revascularization. [4] Age, chronic obstructive pulmonary disease, concomitant coronary revascularization, frailty stratified according to the Geriatric Status Scale, urgent procedure and estimated glomerular filtration rate were independent predictors of 30-day mortality. [5] RESULTS 59 patients were included (mean age 65±10 years, preoperative LVEF 36±6%; effective regurgitant orifice [ERO] 41±17 mm2), 41 with ischaemic disease: 12 underwent UA and 47 underwent MVR; only eight had concomitant coronary revascularization. [6]TAV가 있는 환자는 더 자주 수반되는 관상 동맥 재관류술이 필요했습니다(OR, 3. [1] 일치하는 IMR 환자의 70%에서 동시 관상동맥 혈관재생이 발생했습니다. [2] 이것은 상행 대동맥에서 대퇴골 우회술과 동반되는 관상동맥 혈관재생술에 대한 보다 널리 사용되는 기술에 대한 대안입니다. [3] nan [4] nan [5] 결과 59명의 환자(평균 연령 65±10세, 수술 전 좌심실박출률 36±6%, 유효 역류구[ERO] 41±17 mm2), 허혈성 질환이 있는 41명: UA 12명 및 MVR 47명; 8명만이 관상동맥 재관류술을 받았습니다. [6]
concomitant coronary heart 수반되는 관상 동맥 심장
In this review, we explore the relationship between the liver and the heart in myocardial ischemia, describe epidemiological associations between various liver pathologies and coronary heart disease, and elucidate practical challenges in the clinical management of patients with concomitant coronary heart disease and hepatic abnormalities. [1] The study has demonstrated the relative safety of fluid therapy regimens in patients with concomitant coronary heart disease without manifestations of congestive heart failure during major abdominal surgery. [2] 127 people were examined - 14 healthy (control), 61 patients with stage II hypertension with concomitant coronary heart disease (group 2), 52 hypertensive patients with stage III with concomitant coronary heart disease (group 3). [3] The study aims to analyze the effect of the combination of Mexicor and Polyoxidonium on the cardiovascular system in patients with chronic obstructive pulmonary disease (COPD) and concomitant coronary heart disease (CHD). [4] 14%) than without concomitant coronary heart disease - 35. [5] Lower risks of dementia were also seen in AF patients with concomitant coronary heart disease and congestive heart failure. [6]이 리뷰에서 우리는 심근 허혈에서 간과 심장 사이의 관계를 탐구하고 다양한 간 병리와 관상 동맥 심장 질환 사이의 역학적 연관성을 설명하며 관상 동맥 심장 질환 및 간 이상을 동반하는 환자의 임상 관리에서 실제적인 문제를 설명합니다. [1] 이 연구는 주요 복부 수술 중 울혈성 심부전의 징후가 없는 관상동맥 심장 질환을 동반한 환자에서 수액 요법의 상대적 안전성을 입증했습니다. [2] 건강한 14명(대조군), 관상 동맥 심장 질환을 동반한 II기 고혈압 환자 61명(그룹 2), 관상 동맥 심장 질환을 동반한 III기 고혈압 환자 52명(그룹 3) 등 127명이 검사를 받았습니다. [3] nan [4] nan [5] 관상 동맥 심장 질환과 울혈성 심부전을 동반한 AF 환자에서도 치매 위험이 더 낮았습니다. [6]
concomitant coronary disease
The clinical outcomes vary based on lesion location and complexity of concomitant coronary disease. [1] 9%) and concomitant coronary disease (1. [2] 003), concomitant coronary disease (OR = 2. [3] In this study, we aim to quantify the effect of severe AS on the coronary microcirculation and determine if this is influenced by any concomitant coronary disease. [4]임상 결과는 병변 위치와 수반되는 관상 동맥 질환의 복잡성에 따라 다릅니다. [1] 9%) 및 수반되는 관상동맥 질환(1. [2] 003), 수반되는 관상동맥 질환(OR = 2. [3] 이 연구에서 우리는 관상 동맥 미세 순환에 대한 중증 AS의 영향을 정량화하고 이것이 수반되는 관상 동맥 질환의 영향을 받는지 결정하는 것을 목표로 합니다. [4]
concomitant coronary bypas 수반되는 관상동맥 우회
The concomitant coronary bypass was done for all patients; two-vessel disease was more prevalent (39%). [1] The device could not be retrieved via various percutaneous maneuvers, necessitating an emergency surgical device retrieval and concomitant coronary bypass. [2] Concomitant coronary bypass was performed in 67% and left ventricular repair in 28%. [3]모든 환자에 대해 동시 관상동맥 우회술을 시행했습니다. 이중 혈관 질환이 더 널리 퍼졌습니다(39%). [1] 다양한 경피적 조작을 통해 장치를 회수할 수 없었으므로 응급 수술 장치 회수 및 수반되는 관상 동맥 우회가 필요했습니다. [2] 67%에서 관상동맥 우회술을, 28%에서 좌심실 재건술을 시행했습니다. [3]
concomitant coronary intervention
Procedural considerations such as decision-making for concomitant coronary intervention, antiplatelet therapy after intervention, and follow-up guidelines are also discussed. [1] CONCLUSION CAD is common in asymptomatic older patients referred for screening prior to CHD surgery; however, severe CAD requiring concomitant coronary intervention is uncommon. [2]동시 관상동맥 중재술에 대한 결정, 중재 후 항혈소판 요법, 추적관찰 지침과 같은 절차적 고려 사항도 논의됩니다. [1] 결론 CAD는 CHD 수술 전에 선별 검사를 의뢰받은 무증상의 고령 환자에서 흔합니다. 그러나 관상동맥 중재술을 수반하는 중증 CAD는 드물다. [2]